Close Menu

NEW YORK (GenomeWeb) – In partnership with SAP, the American Society of Clinical Oncology is hoping to develop and launch the first version of its health IT platform CancerLinQ by late 2015, the organization announced today.

In developing CancerLinQ, ASCO is aiming to build a big data framework that will enable doctors to harness real-world patient care data from "millions of electronic health records" – including patients' molecular information – to guide personalized cancer treatment decisions and improve research into precision treatments.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.